New Zealand markets close in 1 hour 5 minutes

Genomma Lab Internacional, S.A.B. de C.V. (LABB.MX)

Mexico - Mexico Delayed price. Currency in MXN
Add to watchlist
14.58+0.50 (+3.55%)
At close: 01:59PM CST
Full screen
Previous close14.08
Open14.10
Bid14.45 x 50000
Ask14.59 x 194200
Day's range14.05 - 14.68
52-week range12.39 - 15.94
Volume2,981,705
Avg. volume3,589,170
Market cap14.063B
Beta (5Y monthly)0.48
PE ratio (TTM)9.66
EPS (TTM)1.51
Earnings date24 Apr 2024
Forward dividend & yield0.78 (5.56%)
Ex-dividend date22 Mar 2024
1y target est18.53
  • PR Newswire

    Genomma Lab Internacional S.A.B. de C.V. First Quarter 2024 Earnings Results Conference Call

    Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company") today announced that it will report its First Quarter 2024 Earnings Results on Wednesday, April 24, 2024, after the Mexican Stock Exchange (BMV) close. The company also announced that it will hold a conference call on Thursday, April 25, 2024, at 1 p.m. ET to discuss its quarterly financial results.

  • PR Newswire

    GENOMMA LAB INTERNACIONAL ANNOUNCES SEVENTH DIVIDEND PAYMENT

    Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company"), one of the leading pharmaceutical and personal care product companies in Mexico with an expanding international presence, informs that the Company filed a Notice of Rights with the Mexican Stock Exchange (Bolsa Mexicana de Valores) declaring a cash dividend of $0.196080 Mexican pesos per share on its common stock representing a total amount of $200,001,600.00 M.N. (two hundred million one thousand and six hun

  • PR Newswire

    Genomma Lab's ESG Rating Upgraded to A

    Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company"), one of the leading pharmaceutical and personal care product companies in Mexico with an expanding international presence, today announced that MSCI, one of the world's largest providers of indices for tracking companies according to environmental, social and governance ("ESG") criteria, upgraded Genomma's MSCI ESG Rating to A from BBB. The upgrade of LABB's ESG Rating is driven by continued improvements in th